In my most honest of moments, what I want from the medical community is the chance to trust it again,” a MAHA advocate writes ...

I didn’t expect to find myself face to face with leaders and activists from the “Make America Healthy Again” movement in respectful dialogue, or to consider inviting one into a public health classroom ...

In this week's STATus Report, host Alex Hogan dives into how sports betting apps hook users — and how he himself fell for some too-good-to-be-true promotions.

The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.

Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of ...

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA?

A smart contact lens described in a research paper on Wednesday combines therapeutic and diagnostic capabilities for glaucoma ...

FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.

Last month, a group of 12 Senate Democrats proposed a framework for rebuilding the health care system. The idea was to spur ...

Steve Ubl, chief executive of PhRMA, plans to step down at the end of the ‌year, after more than a decade leading the main ...